NEW YORK, May 31, 2017 -- Attorney Jonathan Kurta filed a claim earlier this week before the Financial Industry Regulatory Authority, or FINRA, against Capital Financial Services and Questar Capital Corporation. The arbitration claim, filed by two retirees, alleges that financial advisor Steven Knuttila overconcentrated his clients in unsuitable and illiquid investments. Mr. Knuttila has been a financial advisor for nineteen years and is based in Perham, Minnesota. The complaint seeks unspecified money damages due to Mr. Knuttila’s alleged recommendation to concentrate his clients’ portfolios in illiquid private placements, including several oil and real estate investments.
The products at issue were “non-traded,” high risk securities. Non-traded securities disproportionally benefit brokerage firms, who receive larger commissions, while harming investors who are often surprised to learn that they cannot easily liquidate these securities. According to Jonathan Kurta, “this liquidity problem is a particularly troublesome for older investors, who may need access to cash for health care or other unforeseen changes in their lifestyle.”
This is the second customer arbitration that Jonathan Kurta’s law firm, Fitapelli Kurta, has filed against Mr. Knuttila. In addition to the two customer complaints filed by Fitapelli Kurta, Steven Knuttila’s FINRA BrokerCheck report discloses twenty total customer complaints as well as a termination by Questar Capital. According to Jonathan Kurta, “unfortunately, it appears that our clients are among many others who lost money as a result of Steven Knuttila’s alleged wrongdoing and the alleged conduct may have been part of a larger pattern of harming investors in order to generate large commissions.”
Jonathan Kurta is a partner of Fitapelli Kurta, a national law firm, that focuses exclusively on representing investors before FINRA, or the Financial Industry Regulatory Authority. If you would like to know more about this case, please contact Jonathan Kurta at 212-658-1502.
ATTORNEY ADVERTISING
PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



